DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors.
Nielsen AJ, Albert GK, Sanchez A, Chen J, Liu J, Davalos AS, Geng D, Bradeen XG, Hintzsche JD, Robinson W, McCarter M, Amato CM, Tobin R, Couts KL, Wilky BA, Davila E.
Nielsen AJ, et al. Among authors: geng d.
J Clin Invest. 2024 Oct 22:e180278. doi: 10.1172/JCI180278. Online ahead of print.
J Clin Invest. 2024.
PMID: 39436696
Free article.